Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

P D Harvey1, R S Keefe

  • 1Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA. pdharvey@compuserve.com

Abstract

Insights

Novel antipsychotics show promise for improving cognition in schizophrenia patients. However, rigorous study design is crucial for interpreting these cognitive enhancement findings accurately.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Clinical Psychology

Background:

  • Cognitive deficits are a core symptom of schizophrenia, significantly impacting daily functioning.
  • Novel antipsychotic medications are being investigated for their potential to improve cognitive function in schizophrenia.
  • Existing research on cognitive enhancement in schizophrenia exhibits considerable methodological variability.

Purpose of the Study:

  • To review the current state of research on cognitive enhancement in schizophrenia.
  • To highlight the importance of robust study design in assessing the efficacy of novel antipsychotics on cognitive function.
  • To emphasize the need for critical evaluation of research methodology in this field.

Main Methods:

  • Review of existing literature on novel antipsychotics and cognitive function in schizophrenia.
  • Analysis of methodological aspects crucial for assessing cognitive function in clinical trials.
  • Discussion on the standards required for interpretable research outcomes.

Main Results:

  • Novel antipsychotic medications demonstrate preliminary promise for enhancing cognitive functioning in schizophrenia.
  • The methodologies employed to assess the treatment of cognitive deficits in schizophrenia are still under development.
  • Variations in study design impact the interpretability of findings regarding cognitive enhancement.

Conclusions:

  • Researchers and clinicians must critically evaluate the methodological quality of studies on cognitive enhancement in schizophrenia.
  • Methodological weaknesses can limit the interpretability and clinical relevance of research findings.
  • Further standardization of research methodologies is needed to confirm the cognitive benefits of novel antipsychotics.

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...